New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
05:55 EDTBSX, BSX, X, X, TYC, TYC, TROW, TROW, PFE, PFE, PNR, PNR, BTU, BTU, NUE, NUE, NEE, NEE, IP, IP, ITW, ITW, HRS, HRS, HOG, HOG, F, F, EMC, EMC, LLY, LLY, DHR, DHR, GLW, GLW, VLO, VLOCompanies reporting Before the Market Open on Tuesday, January 29
Notable companies reporting before the opening bell on Tuesday include Boston Scientific (BSX), Corning (GLW), D.R. Horton (DHR), Danaher (DHR), Eli Lilly (LLY), EMC (EMC), Ford (F), Harley-Davidson (HOG), Harris (HRS), Illinois Tool Works (ITW), International Paper (IP), NextEra Energy (NEE), Nucor (NUE), Peabody Energy (BTU), Pentair (PNR), Pfizer (PFE), T. Rowe Price Group (TROW), Tyco International (TYC), United States Steel (X), and Valero Energy (VLO).
News For BSX;GLW;DHR;LLY;EMC;F;HOG;HRS;ITW;IP;NEE;NUE;BTU;PNR;PFE;TROW;TYC;X;VLO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
June 18, 2015
06:01 EDTHOGHarley-Davidson upgraded to Buy from Neutral at UBS
UBS upgraded Harley-Davidson to Buy and increased its price target to $63 from $60. The firm upgraded shares based on valuation and new balance sheet strategy following changes at the board and CEO level. Harley-Davidson announced an additional 20M share buyback yesterday on top of the existing 15.9M and UBS believes the move signals a shift in strategy towards shareholder returns.
June 17, 2015
19:55 EDTXU.S. Steel CEO: 'everything on the table' in trying to save company, WSJ says
U.S. Steel CEO Mario Longhi stated that "everything is on the table," including layoffs and changes to its manufacturing process, in trying to save the company, reports the Wall Street Journal. Reference Link
14:39 EDTHOGHarley-Davidson up over 3% after added debt, repurchases seen accretive to EPS
Subscribe for More Information
14:36 EDTHOGHarley-Davidson sees additional debt, repurchases accretive to 2015 EPS
Subscribe for More Information
14:33 EDTHOGHarley-Davidson to repurchase additional 15M shares on buyback program
Subscribe for More Information
13:05 EDTFJ.D. Power: Japanese auto brands struggle to keep up with pace of improvement
With a significant year-over-year improvement, Korean brands continue to widen the quality gap with other automakers, while Japanese makes collectively fall below industry average for the first time in 29 years, according to the J.D. Power 2015 U.S. Initial Quality StudySM released today. Korean brands lead the industry in initial quality by the widest margin ever, averaging 90 PP100, which is an 11 PP100 improvement from 2014. For the first time in the study, European brands surpass Japanese brands, while domestic makes equal the Japanese for only a second time. Porsche (POAHY) ranks highest in initial quality for a third consecutive year, posting a score of 80 PP100. With a 20 PP100 improvement from 2014, Kia follows Porsche in the rankings at 86 PP100. This marks the first time in the history of the study that Kia has led all non-premium makes in initial quality. Jaguar (TTM), Hyundai (HYMLF) and Infiniti (NSANY) round out the top five nameplates. Infiniti is one of the most improved brands in the study, lowering its problem score by 31 PP100 from 2014. Reference Link
12:02 EDTLLYEli Lilly reports LY2951742 meets primary endpoint in Phase 2b migraine study
Eli Lilly announced that its investigational medicine for prevention of migraine -- LY2951742, a CGRP neutralizing antibody -- met the primary endpoint in a Phase 2b study in episodic migraine. The randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of four different doses of LY2951742 given in a once-monthly, subcutaneous injection in more than 400 patients with episodic migraine. The primary objective was to assess whether at least one dose of LY2951742 was superior to placebo in the prevention of migraine headache. LY2951742 demonstrated a statistically significant reduction in migraine headache days and a safety and tolerability profile confirming the previous results seen in a Phase 2a study. In addition to the migraine program, Lilly has initiated two Phase 3 trials with LY2951742 in patients suffering from cluster headache. Based on the unmet medical need and significance of this disorder for patients, Lilly has been granted fast track designation from the U.S. FDA for cluster headache.
10:10 EDTEMCClusterHQ announces collaboration with EMC
ClusterHQ announced integration between ClusterHQ's Flocker container data management software and EMC's ScaleIO and EMC XtremIO storage solutions. As a result, developers and operations teams can architect and manage storage backends for Docker-based applications. EMC collaborated with ClusterHQ to develop pluggable storage drivers for ScaleIO and XtremIO solutions that enable flexible and portable shared storage for Docker.
10:00 EDTPFE, LLYOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AbbVie (ABBV) initiated with an Overweight at Piper Jaffray... Arista Networks (ANET) initiated with a Buy at Sterne Agee CRT... Astec (ASTE) initiated with a Buy at Maxim... Bristol-Myers (BMY) initiated with an Underweight at Piper Jaffray... Community Healthcare (CHCT) initiated with an Outperform at Oppenheimer... Eli Lilly (LLY) initiated with an Overweight at Piper Jaffray... Fitbit (FIT) initiated with a Buy ahead of IPO at Dougherty... Hortonworks (HDP) initiated with a Buy at Mizuho... II-VI (IIVI) initiated with a Buy at Benchmark Co.... J Sainsbury (JSAIY) initiated with an Underperform at Credit Suisse... McDermott (MDR) initiated with an Outperform at Cowen... Merck (MRK) initiated with a Neutral at Piper Jaffray... Molina Healthcare (MOH) initiated with a Buy at UBS... Pacific DataVision (PDVW) initiated with a Buy at Canaccord... Pfizer (PFE) initiated with an Overweight at Piper Jaffray... Quest Resource (QRHC) initiated with a Buy at Roth Capital... Regional Management (RM) initiated with a Buy at Janney Capital... Rofin-Sinar (RSTI) initiated with a Buy at Benchmark Co.... Salesforce (CRM) initiated with a Neutral at Exane BNP Paribas... Sprouts Farmers Markets (SFM) initiated with a Neutral at Cleveland Research... Tesco (TSCDY) initiated with an Underperform at Credit Suisse... WM Morrison (MRWSY) initiated with a Neutral at Credit Suisse... WWE (WWE) initiated with a Buy at BTIG... World Acceptance (WRLD) initiated with a Buy at Janney Capital... Zafgen (ZFGN) initiated with a Buy at SunTrust.
08:45 EDTDHRBofA/Merrill life sciences analysts hold an analyst/industry conference call
Subscribe for More Information
08:10 EDTLLYEli Lilly and Dana-Farber Cancer Institute enter research collaboration
Subscribe for More Information
08:02 EDTLLYEli Lilly partnering with Sarah Cannon Research Institute for oncology therapy
Eli Lilly and Sarah Cannon Research Institute announced a strategic partnership to co‑develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor. Under the agreement, SCRI will collaborate with Lilly to provide clinical development expertise and program design, as well as medical oversight and trial management. Patient enrollment for the initial Phase II clinical trial is underway.
07:25 EDTLLY, PFEPiper calls Bristol 'modestly overvalued,' starts shares with sell
Subscribe for More Information
05:31 EDTPFEPfizer initiated with an Overweight at Piper Jaffray
Target $45.
05:31 EDTLLYEli Lilly initiated with an Overweight at Piper Jaffray
Subscribe for More Information
June 16, 2015
16:38 EDTNEENextEra Energy sees reaffirming FY15 adjusted EPS $5.40-$5.70, consensus $5.65
Subscribe for More Information
10:01 EDTGLWOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:36 EDTLLYEli Lilly price target raised to $100 from $87 at Jefferies
Jefferies raised its price target for Eli Lilly shares to $100 saying that while the market is "overly-obsessed" on the EXPEDITION-EXT abstract for Alzheimer's, the potential for cholesterol treatment evacetrapib should begin to be realized over the next 12 months. Jefferies keeps a Buy rating on Lilly.
08:04 EDTDHRPall Corp. shareholders to vote on Danaher deal at special meeting
Pall Corporation (PLL) announced that it has set the record date for the special meeting of its shareholders to, among other things, consider and vote on a proposal to adopt the previously announced Agreement and Plan of Merger, dated May 12, by and among Pall, Danaher Corporation (DHR), a Delaware corporation, and Pentagon Merger Sub, Inc., a New York corporation and an indirect wholly owned subsidiary of Danaher, providing for the merger of Merger Sub with and into Pall, with Pall surviving the Merger as an indirect wholly owned subsidiary of Danaher. Shareholders of record as of the close of business on June 25 will be entitled to vote at the special meeting. Under the terms of the merger agreement, each share of common stock issued and outstanding immediately prior to the effective time of the Merger will be canceled and automatically converted into the right to receive $127.20 in cash, without interest. The Merger is subject to certain customary closing conditions, including receipt of regulatory approval and approval from its shareholders. The company expects the merger to close by the end of calendar 2015.
06:42 EDTGLWCorning upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital upgraded Corning to Outperform with a $26 price target based on the pending 4K upgrade cycle, accelerating Optical growth, strong cash returns, and improving CY16 earnings growth. The firm believes attractive pricing for 4K TVs could be an upgrade catalyst which will benefit Display and an acceleration in datacenter spending will drive Optical.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use